By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Intercept Pharmaceuticals 



New York City  New York    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Intercept Pharmaceuticals (ICPT) Receives Breakthrough Therapy Designation From FDA For Obeticholic Acid For Nonalcoholic Steatohepatitis (NASH) With Liver Fibrosis 1/30/2015 8:43:18 AM
Intercept Pharmaceuticals (ICPT) Rockets as Lead NASH Drug Snags Breakthrough Status From the FDA 1/30/2015 6:17:48 AM
Intercept Pharmaceuticals (ICPT) Provides 2014 Year-End Update And Planned 2015 Milestones 1/12/2015 8:00:56 AM
Intercept Pharmaceuticals (ICPT) To Present At The J.P. Morgan 33rd Annual Healthcare Conference 1/8/2015 10:34:09 AM
Intercept Pharmaceuticals (ICPT) Announces Publication Of Meta-Analysis From The Global PBC Study Group In Gastroenterology 12/5/2014 9:36:14 AM
Intercept Pharmaceuticals (ICPT) To Present At Upcoming Investor Conferences 11/25/2014 2:05:09 PM
Intercept Pharmaceuticals (ICPT) Appoints Lisa Bright As Head Of Europe 11/17/2014 2:20:33 PM
Intercept Pharmaceuticals (ICPT) Announces Additional Data For OCA In Primary Biliary Cirrhosis 11/10/2014 7:40:52 AM
Intercept Pharmaceuticals (ICPT) Reports Third Quarter 2014 Financial Results And Provides Business Updates 11/7/2014 12:09:32 PM
Intercept Pharmaceuticals (ICPT) Release: FLINT Trial in NASH Published in The Lancet 11/7/2014 6:36:41 AM
123456789
//-->